2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
3
Breast Neoplasms
2
Wilms Tumor
1
Sarcoma, Ewing
1
Ovarian Neoplasms
1
Osteosarcoma
1
Osteoporosis
1
Neuroblastoma
1
Neoplasms
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hepatoblastoma
1
Endometrial Neoplasms
1
Desmoid Tumors
1
Cystic Fibrosis
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Breast Diseases
1
Breast Carcinoma In Situ
1
Interventions
Anastrozole
8
exemestane
7
Trastuzumab
7
Letrozole
7
palbociclib
6
Docetaxel
6
abemaciclib
5
Fulvestrant
5
ribociclib
4
pyrotinib
4
entinostat
4
Cyclophosphamide
4
Tamoxifen
3
Doxorubicin
3
pertuzumab
2
Sodium Chloride
2
Paclitaxel
2
Lapatinib
2
Gonadotropin-Releasing Hormone
2
Exercise
2
Everolimus
2
Epirubicin
2
Drug Evaluation
2
Capecitabine
2
Botulinum Toxins, Type A
2
Blood Specimen Collection
2
Aromatase Inhibitors
2
AZD9833
2
tucatinib
1
trastuzumab deruxtecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Diseases
×
Bone Density
×
Clear all
NCT00842465
2013-11-25
Prolacsein
Assistance Publique - Hôpitaux de Paris
Completed
735 enrolled